Percutaneous closure of patent foramen ovale: safe and effective but underutilized.
Data(s) |
01/02/2015
|
---|---|
Resumo |
With three recently published randomized trials on patent foramen ovale (PFO) closure, the concept of PFO closure to reduce recurrent strokes has been proven; however, PFO closure is currently only considered for secondary prevention. Given the potential devastating consequences of a PFO-related event, we advocate screening for and closure of a PFO for primary prevention in high-risk populations. Such populations include patients who are suffering from a disease that is associated with PFO (e.g., migraine) or patients with high-risk hobbies/professions (e.g., weight-lifters, frequent-flyers, and deep sea divers). Looking at young people with a remaining average life expectancy of 50 years, we have to close 2.4 PFOs to prevent one stroke. This should support a more proactive attitude toward PFO screening and closure. |
Formato |
application/pdf |
Identificador |
http://boris.unibe.ch/64598/1/14779072.2015.pdf Nietlispach, Fabian; Meier, Bernhard (2015). Percutaneous closure of patent foramen ovale: safe and effective but underutilized. Expert review of cardiovascular therapy, 13(2), pp. 121-123. Taylor & Francis 10.1586/14779072.2015.1000305 <http://dx.doi.org/10.1586/14779072.2015.1000305> doi:10.7892/boris.64598 info:doi:10.1586/14779072.2015.1000305 info:pmid:25556896 urn:issn:1477-9072 |
Idioma(s) |
eng |
Publicador |
Taylor & Francis |
Relação |
http://boris.unibe.ch/64598/ |
Direitos |
info:eu-repo/semantics/restrictedAccess |
Fonte |
Nietlispach, Fabian; Meier, Bernhard (2015). Percutaneous closure of patent foramen ovale: safe and effective but underutilized. Expert review of cardiovascular therapy, 13(2), pp. 121-123. Taylor & Francis 10.1586/14779072.2015.1000305 <http://dx.doi.org/10.1586/14779072.2015.1000305> |
Palavras-Chave | #610 Medicine & health |
Tipo |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion PeerReviewed |